Physician profile
Sheeraz Qureshi
NPI 1831303106
$827,830.79
in general payments reported to CMS, 2019-2025
28 companies · $218K in 2025
The $218K reported for 2025 was more than what 96% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $137K · 2021: $179K · 2022: $85K · 2023: $69K · 2024: $83K · 2025: $218K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $185K · Royalty Or License: $134K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $18K · Food and Beverage: $6,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $185,215.00 |
| Royalty Or License | $133,729.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,940.00 |
| Travel and Lodging | $17,501.70 |
| Food and Beverage | $6,212.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $529,914.41 | 2019-2025 | Excelsius Gps, Excelsiusgps Robotic Navigation System, Hedron P |
| Spinal Simplicity, LLC | $104,999.22 | 2020-2021 | |
| Stryker Corporation | $53,618.90 | 2019-2025 | N/A, Cascadia Interbody System, Capri Corpectomy Cage System |
| Viseon, INC. | $33,902.92 | 2021-2022 | |
| Alphatec Spine, INC | $32,208.25 | 2020-2025 | Other - Miscellaneous, Battalion Tlif - Pc, Identiti |
| Nuvasive, INC. | $18,238.00 | 2019-2023 | Xlif, Simplify Cervical Artificial Disc, Pcm |
| Medtronic, INC. | $18,075.13 | 2021-2025 | Prestige Lp Cervical Disc System, Infinity Occipitocervical Upper Thoracic System, Endoskeleton Tc Nanolock Surface Technology |
| Arthrex, INC. | $10,141.72 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $8,552.70 | 2025 | |
| Vb Spine LLC | $6,198.23 | 2025 | Vulcan Spinal System, Canyon Retractor Systems |
| Surgalign Spine Technologies, INC. | $3,843.55 | 2021-2022 | |
| Amplify Surgical, INC. | $2,168.43 | 2021 | |
| Spineguard, INC. | $2,000.00 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $1,421.01 | 2019-2021 | |
| Curiteva, INC. | $435.66 | 2023-2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $392.41 | 2023 | Xvision |
| Si-Bone, INC. | $260.01 | 2024-2025 | |
| Synthes Gmbh | $250.00 | 2021 | |
| Medical Device Business Services, INC. | $242.07 | 2019-2025 | Velys |
| Orthofix Medical, INC. | $214.79 | 2020-2024 | Mariner Mis, M6-C, Newbridge |
| Spine Wave, INC. | $182.70 | 2021 | |
| Mml US, INC. | $178.95 | 2022 | |
| Baxter Healthcare | $125.00 | 2021 | |
| Acumed LLC | $108.85 | 2020 | |
| Biedermann Motech, INC. | $71.39 | 2019 | |
| Djo, LLC | $42.48 | 2024 | Cmf |
| Providence Medical Technology, INC. | $29.10 | 2023 | |
| Medtronic USA, INC. | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$568,291.69 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheeraz Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.